Delivery Order SPE2DR25D9312-SPE2DR26FGEM8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The award, issued on October 20, 2025, carries a ceiling value of $5,567.60 under a firm fixed-price delivery order structure with an ultimate completion date of November 10, 2025. This delivery order was issued without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award represents one...
- The Defense Logistics Agency awarded a $5,567.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for one dose vials of YF-VAX (yellow fever vaccine). The delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order was issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. The delivery order...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries firm fixed-price terms and received no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $5,567.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever vaccine (YF-VAX) 1-dose vials. The delivery order, issued on November 14, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- SPE2DR25D9312Indefinite Delivery Contract
- SPE2DR25D9312-SPE2DR26FGEM8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,567.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in single-dose vials. The contract, designated as delivery order 4570055827, operates under a firm fixed-price structure with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery order carries an ultimate completion date of December 5, 2025, and will be fulfilled at the contractor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements globally. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/13/25 |